Next Article in Journal / Special Issue
Variant of Concern-Matched COVID-19 Convalescent Plasma Usage in Seronegative Hospitalized Patients
Previous Article in Journal
Diversity of SIRV-like Viruses from a North American Population
Previous Article in Special Issue
Nucleopore Traffic Is Hindered by SARS-CoV-2 ORF6 Protein to Efficiently Suppress IFN-β and IL-6 Secretion
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

SARS-CoV-2 Circulation during the First Year of the Pandemic: A Seroprevalence Study from January to December 2020 in Tuscany, Italy

1
Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy
2
Department of Veterinary Medicine, University of Bari, 70010 Valenzano, Italy
3
VisMederi Srl, 53100 Siena, Italy
4
VisMederi Research Srl, 53100 Siena, Italy
5
NeoMedica Srl, 53100 Siena, Italy
*
Author to whom correspondence should be addressed.
Deceased.
Viruses 2022, 14(7), 1441; https://doi.org/10.3390/v14071441
Submission received: 21 April 2022 / Revised: 24 June 2022 / Accepted: 28 June 2022 / Published: 30 June 2022
(This article belongs to the Special Issue State-of-the-Art SARS-CoV-2 Research in Italy)

Abstract

Italy was the second country affected by the SARS-CoV-2 pandemic; the virus spread mainly in Northern Italy with a subsequent diffusion to the center and southern part of the country. In this study, we aimed to assess the prevalence of antibodies against SARS-CoV-2 in the general population of the Siena province in the Tuscany region (Central Italy) during 2020. A total of 2480 serum samples collected from January to December 2020 were tested for IgM and IgG antibodies against SARS-CoV-2 by a commercial ELISA. Positive and borderline samples were further tested for the presence of anti-receptor-binding domain (RBD) IgM and IgG antibodies by an in-house ELISA and by a micro-neutralization assay. Out of the 2480 samples tested by the commercial ELISA, 81 (3.3%) were found to be positive or borderline for IgG and 58 (2.3%) for IgM in a total of 133 samples (5.4%) found to be positive or borderline for at least one antibody class. When the commercial ELISA and in-house ELISA/micro-neutralization assay results were combined, 26 samples (1.0%) were positive for RBD IgG, 11 (0.4%) for RBD IgM, and 23 (0.9%) for a neutralizing antibody. An increase in seroprevalence was observed during the year 2020, especially from the end of summer, consistent with the routine epidemiological surveillance of COVID-19 cases.
Keywords: SARS-CoV-2; Italy; seroprevalence SARS-CoV-2; Italy; seroprevalence

Share and Cite

MDPI and ACS Style

Marchi, S.; Lanave, G.; Camero, M.; Dapporto, F.; Manenti, A.; Benincasa, L.; Acciavatti, A.; Brogi, G.; Viviani, S.; Montomoli, E.; et al. SARS-CoV-2 Circulation during the First Year of the Pandemic: A Seroprevalence Study from January to December 2020 in Tuscany, Italy. Viruses 2022, 14, 1441. https://doi.org/10.3390/v14071441

AMA Style

Marchi S, Lanave G, Camero M, Dapporto F, Manenti A, Benincasa L, Acciavatti A, Brogi G, Viviani S, Montomoli E, et al. SARS-CoV-2 Circulation during the First Year of the Pandemic: A Seroprevalence Study from January to December 2020 in Tuscany, Italy. Viruses. 2022; 14(7):1441. https://doi.org/10.3390/v14071441

Chicago/Turabian Style

Marchi, Serena, Gianvito Lanave, Michele Camero, Francesca Dapporto, Alessandro Manenti, Linda Benincasa, Angela Acciavatti, Giulio Brogi, Simonetta Viviani, Emanuele Montomoli, and et al. 2022. "SARS-CoV-2 Circulation during the First Year of the Pandemic: A Seroprevalence Study from January to December 2020 in Tuscany, Italy" Viruses 14, no. 7: 1441. https://doi.org/10.3390/v14071441

APA Style

Marchi, S., Lanave, G., Camero, M., Dapporto, F., Manenti, A., Benincasa, L., Acciavatti, A., Brogi, G., Viviani, S., Montomoli, E., & Trombetta, C. M. (2022). SARS-CoV-2 Circulation during the First Year of the Pandemic: A Seroprevalence Study from January to December 2020 in Tuscany, Italy. Viruses, 14(7), 1441. https://doi.org/10.3390/v14071441

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop